Benzinga
Benzinga
Actualités France
Bourse
Economie
Général
Actualités Américaines
Bourse
Bénéfices
Economie
Marchés prédictifs
Marchés privés
Autres marchés
Recommandations des analystes
Trading
Communiqués de presse
Mondial
Asie
Crypto-monnaies
Actualités cryptos
Altcoins
Bitcoin
Dogecoin
Ethereum
Shiba Inu
NFT
Éducation
Investir en crypto
Investir en bourse
Forex
Benzinga
mardi, novembre 17
Actualités France
Bourse
Economie
Général
Actualités Américaines
Bourse
Bénéfices
Economie
Marchés prédictifs
Marchés privés
Autres marchés
Recommandations des analystes
Trading
Communiqués de presse
Mondial
Asie
Crypto-monnaies
Actualités cryptos
Altcoins
Bitcoin
Dogecoin
Ethereum
Shiba Inu
NFT
Éducation
Investir en crypto
Investir en bourse
Forex
Strata Critical Medical Inc
SRTA
NASDAQ
Liste de surveillance
Get Report
Trade with Public
Get Report
Trade with Public
$5.42
-0.09
-1.63%
À la clôture: Nov 13, 4:00 PM EST
$4.92
-0.59
-10.71%
Pré-ouverture: 4:28 AM EST
Get Report
Aperçu
Actualités
Graphiques
Prévisions de résultats
Événements
Objectifs de cours
Données financières
Sentiment
Actionnariat
Comparer
Options
Rapport sur les stocks
Strata Critical Medical Financials
Strata Critical Medical (SRTA) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
Strata Critical Medical Affirms FY2026 Sales Guidance of $285.000M-$295.000M vs $290.804M Est
Strata Critical Medical (NASDAQ:SRTA) affirms FY2026 sales outlook from $285.000 million-$295.000 million to $285.000 million-$295.000 million vs $290.804 million estimate.
Benzinga Newsdesk
PRO
Strata Critical Medical Q3 EPS $(0.09) Misses $(0.01) Estimate, Sales $74.081M Beat $72.669M Estimate
Strata Critical Medical (NASDAQ:SRTA) reported quarterly losses of $(0.09) per share which missed the analyst consensus estimate of $(0.01) by 800 percent. This is a 25 percent increase over losses of $(0.12) per share
Benzinga Newsdesk
PRO
Strata Critical Medical Q2 EPS $(0.12) Misses $(0.02) Estimate, Sales $72.506M Beat $67.112M Estimate
Benzinga Newsdesk
PRO
Strata Critical Medical Raises FY2026 Sales Guidance from $260.000M-$275.000M to $285.000M-$295.000M vs $275.746M Est
Strata Critical Medical (NASDAQ:SRTA) raises FY2026 sales outlook from $260.000 million-$275.000 million to $285.000 million-$295.000 million vs $275.746 million estimate.
Benzinga Newsdesk
Earnings Scheduled For May 6, 2026
Benzinga Insights
PRO
Strata Critical Medical Affirms FY2026 Sales Guidance of $260.000M-$275.000M vs $269.175M Est
Strata Critical Medical (NASDAQ:SRTA) affirms FY2026 sales outlook from $260.000 million-$275.000 million to $260.000 million-$275.000 million vs $269.175 million estimate.
Benzinga Newsdesk